Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 693 of 1,261
  1. US 9346858

    Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

    The Regents of the University of California · Granted May 24, 2016 · Expires May 19, 2036

    granted
  2. US 9346822

    Thienopyrimidine compounds and use thereof

    Takeda Pharmaceutical Company Limited · Granted May 24, 2016 · Expires May 19, 2036

    granted
  3. US 9346783

    Method and apparatus for producing oxidized compound

    Takeda Pharmaceutical Company Limited · Granted May 24, 2016 · Expires May 19, 2036

    granted
  4. US 9346776

    Fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 24, 2016 · Expires May 19, 2036

    granted
  5. US 9346765

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 24, 2016 · Expires May 19, 2036

    granted
  6. US 9346759

    Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisytlate as agonist of the β2 adrenergic receptor

    Almirall, S.A. · Granted May 24, 2016 · Expires May 19, 2036

    granted
  7. US 9345781

    Targeted dendrimer-drug conjugates

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 24, 2016 · Expires May 19, 2036

    granted
  8. US 9345775

    Compositions for targeted delivery of siRNA

    Arrowhead Madison, Inc. · Granted May 24, 2016 · Expires May 19, 2036

    granted
  9. US 9345790

    Cobalt-based MRI contrast agent and imaging system

    The Board of Regents of the University of Texas System · Granted May 24, 2016 · Expires May 19, 2036

    granted
  10. US 9345748

    Anti-SSX-2 T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 24, 2016 · Expires May 19, 2036

    granted
  11. US 9345713

    6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted May 24, 2016 · Expires May 19, 2036

    granted
  12. US 9345718

    Phospholipid ether analogs as cancer-targeting drug vehicles

    CELLECTAR BIOSCIENCES, INC. · Granted May 24, 2016 · Expires May 19, 2036

    granted
  13. US 9340789

    UNA oligomer structures for therapeutic agents

    ARCTURUS THERAPEUTICS, INC. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  14. US 9340572

    Taccalonolide microtubule stabilizers

    The Board of Regents of the University of Texas System · Granted May 17, 2016 · Expires May 12, 2036

    granted
  15. US 9340576

    Methods of treating depression and other related diseases

    Northwestern University · Granted May 17, 2016 · Expires May 12, 2036

    granted
  16. US 9340557

    Substituted quinoxaline DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 17, 2016 · Expires May 12, 2036

    granted
  17. US 9340547

    Pyrrolotriazinone derivatives as inhibitors P13K

    Almirall, S.A. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  18. US 9340522

    Pyrazolone-derivatives and their use as PDE-4 inhibitors

    TAKEDA GMBH · Granted May 17, 2016 · Expires May 12, 2036

    granted
  19. US 9340538

    Dihydropyrimidine compounds and their application in pharmaceuticals

    SUNSHINE LAKE PHARMA CO., LTD. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  20. US 9339545

    Stable formulations for parenteral injection of peptide drugs

    XERIS PHARMACEUTICALS, INC. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  21. US 9339528

    Methods for treating epithelium trauma of the intestinal mucosa using interleukin-1 receptor antagonist

    GENERAL REGENERATIVES, LTD. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  22. US 9339513

    Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes

    Alnylam Pharmaceuticals, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  23. US 9339507

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted May 17, 2016 · Expires May 12, 2036

    granted
  24. US 9339495

    Methods of increasing tonic inhibition and treating secondary insomnia

    OVID THERAPEUTICS INC. · Granted May 17, 2016 · Expires May 12, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.